Content Navigation
( All
None )
Target General Information |
Top |
Target ID |
T14731 |
Target Info
|
Target Name |
NAD-dependent deacetylase sirtuin-1 (SIRT1) |
Synonyms |
hSIRT1; hSIR2; SIR2L1; SIR2-like protein 1; Regulatory protein SIR2 homolog 1; NAD-dependent protein deacetylase sirtuin-1 |
Target Type |
Clinical trial Target |
Gene Name |
SIRT1 |
Biochemical Class |
Carbon-nitrogen hydrolase |
UniProt ID |
|
Patent(s) and the Corresponding Patented Drug(s) |
Top |
World Intellectual Property Organization (WIPO) |
Patent ID |
WO2012106509 |
Title |
Sirtuin Modulators As Virus Production Modulators. |
Abstract |
Agents and methods of inhibiting or improving the growth of viruses are provided. |
Applicant(s) |
The Trustes of Princeton University |
Representative Drug(s) |
D02QKC |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D04JZE
|
Drug Info
|
N.A.
|
[1] |
3
|
D06IHB
|
Drug Info
|
N.A.
|
[1] |
4
|
D0E3LP
|
Drug Info
|
N.A.
|
[1] |
5
|
D0PE8E
|
Drug Info
|
N.A.
|
[1] |
6
|
D0U3EP
|
Drug Info
|
N.A.
|
[1] |
References |
Top |
REF 1 |
Sirtuin modulators: an updated patent review (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):5-15.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.